Ledger.Open graph →
SEC Form D · Amendment · filed April 28, 2025

BigHat Biosciences, Inc

Offering
$124.1M
Sold
$124.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN MATEO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Vineeta Agarwala · San Mateo, CADirectorFrancisco Gimenez · San Mateo, CADirectorSteve Kafka · San Mateo, CADirectorPeyton Greenside · San Mateo, CAExec · DirectorRobert Chess · San Mateo, CADirectorMichael Ulliman · New York, NYDirectorKaleb Dasinger · Sidney, MTExec · DirectorSpencer Clawson · Salt Lake City, UTDirectorJames Lee · Sidney, MTDirectorJoel Brown · Sidney, MTDirectorScott Richardson · New York, NYDirectorEmory L. Lowe · PEACHTREE CORNERS, GADirectorRaymond Debbane · New York, NYExec · DirectorMassandra Capital VIII, LLC · Irvine, CADirectorYolanda Banks Mccoy · George Town, Grand Cayman, Cayman IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗